Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients

NCT03881384 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

OTHER: ctDNA level during neoadjuant chemotherapy

Sponsor

First Affiliated Hospital Xi'an Jiaotong University